Vislube

Vislube Overdosage

sodium hyaluronate

Manufacturer:

TRB Chemedica

Distributor:

DKSH

Marketer:

TRB Chemedica
Full Prescribing Info
Overdosage
Given the nature of the product and the route of administration, no problems of overdosage are expected as the excess fluid will flow from the eye. A toxicology study following topical ocular administration of VISLUBE, conducted in the rabbit, showed that overdosing with VISLUBE did not result in any clinical or histological adverse events.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in